However, in partial responders or those unable to escalate dose, future strategies may involve agents such as peripherally acting cannabinoid type 1 receptor antagonists, FGF21 analogs, amylin mimetics, or emerging triple agonists like retatrutide, which target GLP-1, GIP, and glucagon receptors simultaneously
It seems that semaglutide used for weight loss among patients with obesity does not meet typical cost-effectiveness standards
Injectable microdose protocols can achieve sub-0.25 mg precision, while oral formulations present technical limits around 0.25 mg tablets or compounded lower-strength options
The efficiency of various nutrition education approaches in imparting general and sport nutrition knowledge to athletes has not yet been assessed, yet
When Should I Consult My Doctor